Gameto Expands Phase III Fertilo Trial to Leading New York Fertility Center

According to a recent LinkedIn post from Gameto, the Phase III clinical trial of its Fertilo program is expanding in the U.S. with the addition of Columbia University Fertility Center in New York as a new site. The post notes that the center, led by Dr. Eric Forman, was ranked the top fertility clinic in the nation in Newsweek’s 2025 America’s Best Fertility Clinics and is currently the only New York site participating in the study.

The company’s LinkedIn post suggests that the opening of this site increases geographic coverage and patient access, with eligible New York patients reportedly able to access Fertilo with covered cycles. For investors, the continued expansion of a Phase III trial at a high-profile academic clinic may indicate trial momentum, potential for stronger enrollment, and validation from a leading fertility center, factors that could be relevant to regulatory and commercialization prospects if the program is successful.

As shared in the post, Gameto indicates that more trial sites and updates are expected, and directs readers to additional locations via its bio link. This trajectory may imply a scaling strategy in key U.S. fertility markets and could position the company more competitively in women’s health and IVF-related therapeutics, although ultimate financial impact will depend on clinical outcomes, payer adoption, and the broader reproductive medicine landscape.